Hepatitis B Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions.
about
Hurdles to the Development of Effective HBV Immunotherapies and HCV VaccinesRisk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients with undetectable serum HBV DNA after treatment with rituximab for lymphoma: a meta-analysis.Comprehensive Review on Colorectal Cancer and Transplant.Epigenetic Regulation of Hepatitis B Virus Covalently Closed Circular DNA: Implications for Epigenetic Therapy against Chronic Hepatitis B.Hepatitis B in patients with hematological diseases: An update.Eighteen-month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy.HBV-related acute hepatitis due to immune checkpoint inhibitors in a patient with malignant melanoma.Humoral immunity, the underestimated player in hepatitis B.Hepatitis B Virus Infection and Organ Transplantation.Safety of Tocilizumab in Rheumatoid Arthritis Patients with Resolved Hepatitis B Virus Infection: Data from Real-World Experience.Hepatitis B infection reported with cancer chemotherapy: analyzing the US FDA Adverse Event Reporting System.Liver Illness and Psoriatic Patients.Disease Characteristics and Change in Arthritis Activity according to Treatment in Hepatitis B Surface Antigen-positive Rheumatoid Arthritis Patients: a Retrospective Chart Review Study.A Chimeric Humanized Mouse Model by Engrafting the Human Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cell for the Chronic Hepatitis B Virus Infection.Hepatitis B Virus Adaptation to the CD8+ T Cell Response: Consequences for Host and PathogenEffects of rituximab dose on hepatitis B reactivation in patients with resolved infection undergoing immunologic incompatible kidney transplantationHepatitis B Virus (HBV) Infection and Re-activation During Nucleos(t)ide Reverse Transcriptase Inhibitor-Sparing Antiretroviral Therapy in a High-HBV Endemicity SettingA quantile regression approach to explain the relationship of Fatigue and Cortisol, Cytokine among Koreans with Hepatitis BCirculating and intrahepatic antiviral B cells are defective in hepatitis B
P2860
Q33840260-2898D509-F139-4BC1-AD2F-80C46990F729Q38601007-6999B623-75D1-4B1E-BF5F-AD5B7E2B6B8DQ38687757-066DB177-F7E7-41EE-8271-945C1C2395F5Q40073818-ABB88DDA-874B-4142-982E-FCB875224C75Q41690596-B41C39AC-650D-4039-9AF8-0E339C8551F3Q45326378-2E5F44F6-28A9-4023-A582-7773DFDCA56FQ49842987-7AF014AA-2D33-41D8-9BAE-ABD19B5B1AC3Q49962982-9D671270-4786-4E95-85D1-AA96DFA8138EQ50326421-90CD4F10-24C2-4CE9-BDDC-EC2373A69F65Q53075897-540B9B21-60F9-471D-8878-8FF694B2E7F5Q54234367-1C043BCF-130B-4F81-AD0A-7DA2BBD0FC8BQ54254957-CC12885A-F2E1-4E0D-B9A9-7B53D2BA7859Q54984291-EE7143BB-E137-4B8B-95C4-D32C9DFC2DC2Q55325868-7940337B-11A5-4C49-89CB-8A32F0AE89ECQ56918262-39A2300D-75A9-4CE5-AD6C-60F05D1A678EQ57799933-AA990863-E17B-4D29-AF26-D14AE74DAC47Q58123468-C5F2E08C-09E2-48CD-BA09-44DE45B72236Q58608804-B0ABF2DB-971F-4A41-8305-51EB4501AB84Q58792007-72B34838-0B06-47BA-8052-6A69B4B739B6
P2860
Hepatitis B Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Hepatitis B Reactivation Assoc ...... tegies, and Future Directions.
@en
type
label
Hepatitis B Reactivation Assoc ...... tegies, and Future Directions.
@en
prefLabel
Hepatitis B Reactivation Assoc ...... tegies, and Future Directions.
@en
P2860
P1433
P1476
Hepatitis B Reactivation Assoc ...... tegies, and Future Directions.
@en
P2093
Rohit Loomba
T Jake Liang
P2860
P304
P356
10.1053/J.GASTRO.2017.02.009
P407
P577
2017-02-20T00:00:00Z